Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange ArcaETF
$44.1456
+$0.9012 · +2.08%
As of Oct 9, 3:53 PM ET
Regular session · ET · Market data may be delayed.
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Fund facts updated Oct 10, 2026.
Day range
Current $44.1456
52-week range
Current $44.1456
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
1 month
-11.55%
3 months
-16.96%
Year to date
+14.49%
1 year
+52.23%
3 years
+125.81%
5 years
-1.28%
Since inception
+65.34%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 130 reported holdings
Displayed portfolio weight: 19.39%
Holdings data updated Oct 10, 2026.
Dec 22, 2025
Dec 22, 2025
Dec 29, 2025
$0.6554
Annual
Dec 20, 2024
Dec 20, 2024
Dec 27, 2024
$0.2395
Annual
Dec 20, 2023
Dec 21, 2023
Dec 29, 2023
$0.0823
Annual
Dec 20, 2017
Dec 21, 2017
Dec 27, 2017
$0.2972
Annual
Dec 21, 2015
Dec 23, 2015
Dec 29, 2015
$0.147
Annual
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
